(redirected from bladder tumor)
Also found in: Dictionary, Medical, Encyclopedia.
Related to bladder tumor: Bladder cancer
Graphic Thesaurus  🔍
Display ON
Animation ON
  • noun

Synonyms for tumor

References in periodicals archive ?
In addition, the higher cost of the initial use of PDD cystoscopy for cases with bladder tumor has been considered.
Telomerase, an enzyme present in greater than 80% of all cancer cells, has the potential to be a successful bladder tumor marker for cancer surveillance and monitoring.
Professional urology associations and NCCN Guidelines recommend instillation of a cytotoxic agent following transurethral resection of bladder tumor (TURBT) for NMIBC.
Hexaminolevulinate is equal to 5-aminolevulinic acid concerning residual tumor and recurrence rate following photodynamic diagnostic assisted transurethral resection of bladder tumors.
Because only symptomatic patients with clinical signs of bladder cancer or patients with known bladder cancer were included in this study, the decision threshold of an earlier clinical evaluation of the BTA TRAK assay was used to select patients with a bladder tumor.
Comparative evaluation of the BTAstat test, NMP22, and voided urine cytology in the detection of primary and recurrent bladder tumors.
From all patients, selected site biopsies were taken from eight predefined sites in the bladder when the bladder tumor was removed.
Patients with recurrent carcinoma in situ bladder tumors who fail traditional therapy have been significantly underserved due to the lack of available approved treatment alternatives, and VALSTAR will provide a well-tolerated treatment option for these patients," said Dave Holveck, president and chief executive officer of Endo Pharmaceuticals.
Inflammatory Myofibroblastic Bladder Tumor in a Patient with Von Recklinghausen's Syndrome.
BTA stat(R) Test Detects Bladder Tumor Associated Antigen in Urine
Their study, The Cost Effectiveness/Efficacy Algorithm Concerning Molecular Diagnosis of Bladder Carcinoma: With or without Cystoscopy, utilized a decision analysis model based on national statistics and a recent study of high-risk patients, to evaluate the cost of screening individuals at high risk (based on risk factors such as long-term smoking or exposure to chemicals and dyes) with bladder tumor markers.
In fact intravesical administration exposes the bladder tumor to higher levels of drugs that may prevent tumor cells from becoming invasive and spreading (metastasizing) to other organs.
Case report: lymph node metastasis of micropapillary bladder tumor that completely responded to radiation therapy.
In research involving 44 patients at Erlangen University Medical School, after removing the bladder tumor through the urethra, the remaining cancer cells were treated with combined chemotherapy and/or radiation plus hyperthermia therapy using the BSD-2000, with a complete remission rate of 96%-100% for T1 and T2 tumors.
The Phase 2b study was a multicenter, single-arm, open-label safety study with the objective of assessing the effect on surgical wound healing and systemic absorption of EOquin when given intravesically as a single dose immediately after transurethral resection of bladder tumor (TUR-BT).